Language selection

Search

Patent 2013770 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2013770
(54) English Title: USE OF LIPOSOMES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO WOUNDS, CUTS AND ABRASIONS
(54) French Title: UTILISATION DE LIPOSOMES POUR LA LIBERATION D'AGENTS THERAPEUTIQUES DANS LES PLAIES, LES COUPURES ET LES ABRASIONS
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 09/127 (2006.01)
  • A61K 09/00 (2006.01)
(72) Inventors :
  • SHAW, JACK M. (United States of America)
  • CORDOVA, DIANA M. (United States of America)
(73) Owners :
  • ALCON LABORATORIES, INC.
(71) Applicants :
  • ALCON LABORATORIES, INC. (United States of America)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1990-04-03
(41) Open to Public Inspection: 1990-10-04
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
333,164 (United States of America) 1989-04-04

Abstracts

English Abstract


ABSTRACT
Methods for delivering therapeutic agents to wounds in
liposomes which preferentially bind to the wounds are disclosed.
Methods for delivering therapeutic agents in liposomes to wounds
on the ocular surface of the eye are included.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method for treating ophthalmic wounds with therapeutic
agents for such treatment, which comprises:
applying topically to the affected eye a composition
comprising an effective amount of a therapeutic agent in
liposomes which adsorb to the wounds.
2. The method of claim 1 wherein the liposomes comprise about
50-90 mol% synthetic or naturally occurring phospholipds and
about 10-50 mol% cholesterol.
3. The method of claim 2 wherein the phospholipid is selected
from the group consisting of:
phosphatidylcholine, phosphatidylglycerol,
phosphatidylethanolamine and phosphatidylsarine with acyl chains
of from 14 to 18 carbons, said chains being saturated or
containing one unsaturated bond.
4. The method of claim 2 wherein the liposomes comprise about
50 mol% phosphatidylcholine, about 30 mol% phosphatidylglycerol
and about 20 mol% cholesterol.
5. The method of claim 4 wherein the liposomes are about 10 to
10,000 nm in diameter.
6. The method of claim 1 wherein the liposomes are about 10 to
10,000 nm in diameter.
7. The method of claim 8 wherein the liposomes are about 20 to
500 nm in diameter.
14

8. The method of claim 1 wherein the composition further
comprises polymer in an amount sufficient to provide the
composition with a viscosity of between about 5 cps. and 1000
cps.
9. The method of claim 8 wherein the composition the
liposomes comprise about 50-90 mol% synthetic or naturally
occurring phospholipids and about 10-50 mol% cholesterol and the
polymer concentration is between about 0.25-3.0 wt.%.
10. The method of claim 8 wherein the polymer is selected from
the group consisting of polysaccharides, gelatins, albumin,
casein, chitosan, collagen, polylactide, polylactideglycolide
copolymer, polyorthoesters, polymethacrylate, polyvinylalcohol,
polyacrylic acid, polyvinylpyrrolidone, polyhydroxyethyl-
methacrylate, polyesteramides, polyethyleneglycol and polymeric
amino acids.
11. The method of claim 10 wherein the polymer is a gelatin.
12. A method for treating an ocular wound resulting from surgery
to promote the healing of the wound, which comprises:
applying topically to the wound a pharmaceutical
composition comprising an amount of a drug sufficient to promote
healing of the wound, said drug being contained in liposomes
adapted for selective binding to the wound by means of
adsorption.
13. The method of claim 12 wherein the liposomes comprise about
50-90 mol% synthetic or naturally occurring phospholipids and
about 10-50 mol% cholesterol.

14. The method of claim 13 wherein the phospholipid is selected
from the group consisting of:
phosphatidylcholine, phosphatidylglycerol,
phosphatidylethanolamine and phosphatidylsarine with acyl chains
of from 14 to 18 carbons, said chains being saturated or
containing one unsaturated bond.
15. The method of claim 12 wherein the liposomes are about 10 to
10,000 nm in diameter.
16. The method of claim 12 wherein the liposomes are about 20 to
500 nm in diameter.
17. The method of claim 12 wherein the drug is EGF.
18. A method of selectively delivering a drug to an ophthalmic
wound site, which comprises:
applying topically to the eye an ophthalmic
pharmaceutical composition comprising liposomes containing a drug
in an amount sufficient to achieve the desired therapeutic
result, said liposomes having an affinity for binding to the
ophthalmic wound site by means of adsorption.
19. The method of claim 18 wherein the liposomes comprise about
50-90 mol% synthetic or naturally occurring phospholipids and
about 10-50 mol% cholesterol.
20. The method of claim 19 wherein the phospholipid is selected
from the group consisting of:
phosphatidylcholine, phosphatidylglycerol,
phosphatidylethanolamine and phosphatidylsarine with acyl chains
of from 14 to 18 carbons, said chains being saturated or
containing one unsaturated bond.
16

21. The method of claim 19 wherein the liposomes comprise about
50 mol% phosphatidylcholine, about 30 mol% phosphatidylglycerol
and about 20 mol% cholesterol.
22. The method of claim 21 wherein the liposomes are about 20 to
300 nm in diameter.
23. The method of claim 18 wherein the liposomes are about 10 to
10,000 nm in diameter.
24. The method of claim 23 wherein the liposomes are about 20 to
300 nm in diameter.
25. The method of claim 18 wherein the composition further
comprises a polymer in an amount sufficient to provide the
composition with a viscosity of between about 5 cps. and 1000
cps.
26. The method of claim 25 wherein in the composition the
liposomes comprise about 50-90 mol% synthetic or naturally
occurring phospholipids and about 10-50 mol% cholesterol and the
polymer concentration is between about 0.25-3.0 wt.%.
27. The method of claim 25 wherein the polymer is selected from
the group consisting of polysaccharides, gelatins, albumin,
casein, chitosan, collagen, polylactide, polylactideglycolide
copolymer, polyorthoesters, polymethacrylate, polyvinylalcohol,
polyacrylic acid, polyvinylpyrrolidone, polyhydroxyethyl-
methacrylate, polyesteramides, polyethyleneglycol and polymeric
amino acids.
28. The method of claim 27 wherein the polymer is a gelatin.
17

Description

Note: Descriptions are shown in the official language in which they were submitted.


SENT ~r:L~wE PRIC~ L~LANC ... i 4- 2-9U ilO:4~AM; 703~841124-' 3~1 13~8;~ 3
~ 01377~
~H@ WE B~ L~ 011 ~HC ~IL~UY 0~ PW~lC
1nv~ntlon l~ d1r6ct~d to ~thod~ f~r troat1ng
wound~, OU~5, ~nd ~br~lan~ d ~ ln~ury, tr~uma, ~ur~ry or
bt~o~ th~ou~h th~ d~llv~ry ol' thar-p~ltlc h~-l1n~ a~t- t~
uch ~1t~ls. ~ p~rtlcul~ h~ nt1~ dlr ~t~d to th~
dellvory o~ th~r~pwttc ~nt~ ~o ~oundt, cut~ ~nd abr~10n- on
th~ corne~ or oc~ r ~ur~co o~ tho ~y~ 11PD~Om~ and
11poson~-~ol~r c~pwlt10n~ ~hlch ~wclflc~llg ~dt~r~ or a~h~r~ :
to tha ~ount, cut o~ ~br~lon.
L1po~ r~ uc or v~tcls~ yor st~uc~4ra-
m~d~ ol~ pho~phol1p1d~. For ~n ln~d-pth ~l~cuJslon ot th~
pr~p~r~t~on ~nd proportl~ o- llpo~ , lncorpor~tlon o~ d~ug~
Jlnd p~ot~ln~ th-r~ n~ t~r~a~ ~ru~ dol1nry;
~r~tr1~d~ D=~x~ Vot~ nd ~II, CR~Pr~
~n~.~ eOc~ R~on, ~lor1~ ~, th~ cont-nt~ o~ ~b1eh ~r-
~ncorporJlt~t h~a1n by r~f~r-nc~.
~ h~ U~- o~ 11po~ d~l1v~ry vQhtcl~ to~ dru~ or
oth~r ~h~r~p~ut1c ~pnt~ ~ kno~. Llpo~ u tol1v-ry
vqh1cl~s o- th~npwtle 4l!~nt- to th~ ~ra 1~ ~1JO lulo~n t for
tx~ , U.S. P~t~nt No. ~,5~,0~71s~ d to R. K~ tan, M~rch 10.
198~ d~sGlo~l~g th~l tr~-tm~llt o~ tr~ tte or ~ 1e~1 :
ph~e~n~phyl~etle ~ntophth~ ltl~ or l~V~ltl~ o~eurrln~l throu~hou~ :th~ a~ ~lob~ ~ toP1eal ~1n1~tr~t10n o~ cyelo~por1n tl~
~u1t~bl~ ~x~lpl~nt~, ~ncluglng ll~w~ . U.5. ~a~nt No.
4,6~,57~ u~d to Fou~lttl~ ~t ~ y 13, ~9~B ~1JC1OU~ th~
pr~p~r~t10n o~ b10-ctlY- ~g~nt ~rry1n~ l~P~ 1cl-- ~h1ch o~n
b~ ~pp11~d toplc~lly hr th- trut~ant of oe~ P d~ a such
:
'
'.'' , ' '. ' .. ` ', ' ` ' ',, , , ' ~' . ' '~
' ~' ' , ' ' . " . I
~; ` ~ . ' ', , . :

S~NT BY;L~W~PRIC~ L~B~ANC . . .; 4- 2~ 47AM; 7~36~41124-~ 3~1 139~;~ 4
20~ 377~ `
91~uco~. ~uto t ~ 1n ~C~
Vol.103, No.~, M~ 9a~ ~tclo~ th~ d~l1vor~ o~ 5-~luoro
ur~c~l ln ~11p~ o vl- ~ukon~unct1v-7 ln~-ct101l u ~ ~thoC
for lnhlb1tlna ~l~roblu~ proll~r6t~0n ~ollo~ln~ e~rlor
~cl~r~cto~10~. ~kut~ ~t ~1. char~ct~rlz~ thc~r d~llv~lry Iy~t~
~ ~n ~d~nt~Dus, ~u~t~n~d r~ s~ d 11v-r,y ~ t~ prlon
~tho~s 0~ tra~tm~nt ~lth th~ ~r~ dru~ r~qutr~t ~Mquult
~ukon~nctlY~ etlolls.
-
Th~ u~ o~ t1po~ or c~rt~ln t~p-s o~ t-r~tet dru~
d~lt n ry 1n ~h~ hu g~en d--cr1b d ~r~Y1~u~ly~ Horlsy ~t
~l., ln J. I~ ulal " Vol.~6, No. 2 (J~nuary 1~ ) d~clo~
th~ t~r~ottn~ of dru~lo~dt~ 11po~o~ s to W-rp~ S1apl~x vlru~
~SV) 1nt~ct~ corn~l c~ , 1n Y1tro. Th~ t~rgot1ng ~o1~t~
1ncorpor~tcd ln th~ llpo~o~ ntlvlr~l ~4noclon~1 ~ntlbody
to ~eoprot~1n 0 ot HS~ cont~1n1ng ~ en ~lcntly~ounJ ~tt~ ~c~l
ch~ln. ~hl~ ~1m~4nollp0~0~0~ sho~n to blnd ~poc1~1s~ t~
~SV lnt~ct~d r~ t corn ~l c~ . ln ~noth~r ~x-~pl~ o~ t~rptcd
~ruo d~11 n ry, lntr~vltr~lly 1n~oct~d ll~o~om~ r~ uud ~or
dc ry of drugJ to tbo e~ of th~ r~t1n~ m~r~n~, ~n,
St~r~ v~tl~!t~v~ ~htl~ nd ~ SC~
Vol. U, No.~, ~M~y, 194~). U.S. ~tont No. ~,7~6,~S~ 1J~U~J to
H~th ot ~1. (Jul~ ~, 198~ tl~clo~ tho u~ ot 11po-o~
~nc~p~ul~t~d ~nt~ ~eh ~- ~ fluoropyrl~dtn~- us- hl 1n
pr~Y-nttng ~c~r ~on~t10n b~ lnhlb1tlng c-ll contr-ctlon ~nd c~ll
~ro~h 1n 1~4~tH~ t1~w~ ~n th~ ~y~. H~th t ~ erlh ~
~rl~y of ~onl-nt ~d1~1c~tlon~ o~ th- ll p~o~o u-1ng llg~nds
~nd ronptor~ ~or t-roottng to p~el~lc c~ rf~eo~ or or
n~ blndlng.
Th~ pr~p-r-tlon ~n~ u~ o~ b10~dh-~1vo 11POSO~J ~cr
eOplc~l ~ppl1c~t10n o~ thor~poutt~ nt~ to th- o w1~r ur~ac~
h~ o bon do~srltod. ~oslt1v~1y-ch~rg-~ llposo~ nd
po~y~4r~ ~r~ kno~n h r th~1r ~on~p~ct~lc b10~h-~10n to ~urf~oo
:- i ,. ~. . . . ~ , ,. ,,,
- .. . ... : - ~ , . . . .

SENr BY:L~WE PR1CE L~LANC .. ; 4- 2-9~ ilO:4~AM; 703~841124' 3~1 13~ 5
2~1377
rl~o10n~ o~ y~ , F1t~r~
~b~l~, Vol.~9, 1~p.611~49û, ~ 7)~ uld Shlot~ ~t
AR~10 Annllal M~t1n~ Ab~trut ls~u~ p.~ O.~a ~ 3.
~ ho ~ol~ ~lgur~ lllu-tr~t~ o~ptlon of llpo~ of
th~ pr~ont 1nv~ntlon to corn~ oun~ v~-u- th~lr rol~ttv~ ~
non~orpt1~n to unwoun~ corn~a~.
~L~
~ ht~ lnY~nt1Dn tt d1rut~ to ~tho~t ~or tr~tln~
~ou~d~ ~ th~ d~l1v-r~ of ~h~r~psqt~e ~o~ ln 11po~ to th~
~un~ ~lt~ ~he 11po~ ro~ront1~11y ~d~orb ~o ~oun~ l1t~
~n~ not to h~althy tl~u~ sllrroundln~ tho ~lto~.
~ or- p~rtleul~rly, the 1nnn~10n 1s dlroeto~ to tho
~11v~ry o~ th~r~p~utle ~gent~ ~n 11po~ o ItouRd- on th~
ulrf~e~ o~ th~ ueh u thn oorn~ o~un¢t1v~ ~nd ~el~r~.
~ea4-- th- l~poso~ cl~rrl~r~ ~10~ t ~xelu~1v~1~ to th~
Hound ~1t~ on thc ocular ~rt~e~, th~ ~ount ot th~r~pout1c ~e~nt
norm~lly ~n1-t r-d ~ g~nt c~n h ~10n1~ tly
r2duc~d. Con~u~ntly, th~ th~i-p-ut~c ln~ox or ~r~tn of ~a~ty
o~ ~ drug d-llv-r~t ucordln~ to th~ ~thod o~ el~1~ 1nv~ntlon
wtll b~ 1~prov~.
AlthQqgh toplc~l oph~h-l~1c ~p~t1C~tlO~ of ~
cont~lnlng ltpo~ h~ pr10r Joll~y ~thod~ h~vo
b~oll u~t ~ n~ ~or ~0pro~1nQ th~ tr~n~port o~ th0r~psut1c
~nt~ lnto ~nt ~cro~ t1c~ b~rrhr~ of th~ ~yo~ ~uch ~ th~
co~n~ on3l;n~t1v- uld ~c~or~ ot~b~- ~nd ~10~h~ 6
llposom~t i~ch u tho~ elo~ ~y Norl~y ~t ~ nd
~ 3
: ... .. .. -~, . .
: : . : . . ,. .~

S~NT BY;L~WE PRIC~ L~BLANG . . .; 4- 2-80 ;1~:48AM; 7~3~B41124 ' 3~1 13~8;# ~
~" 2~37~
.
~hlot~ ~t ;~ tlst7) h~vo h~n ~or~ul-t-t through ~1thor cov-l-nt
modl~le~t~on o~ th~ pho-photlp~d or lntorc~l-t1On o~ nt
~410tul~ lnto tho 11po~o~o b11~ r lho uu o~ co~plo~
r~a ptor~r~co~nltlon ll~nd~, or po~1tlvol~ eh~rpd eo~pon~t~
h~v~ hon d~v~d ~ t~rg~t1n~ ~pont~ or non~p c1~10 ~10~dh ~1v-
co~pon~nt~ for t1~wo ur~co~ Ho~ovor, prlor ~thod- h~n not
r~e~n~toJ th~t llpo~oo-- ~1tl pr~crcnt~lly blo~or~, ~lth
hlgh dc~rc o- ~p~c1~1c1t~. to cor~ool ~ount~ ch U cut~ ~nd
~br~lon~ ~h~ pronnt lnYontlon 1~ h~d on tho pr1~1ng
d1~co~ry th~t l~po-on~ re to ~ou~d ~1to~ but not ~o th.
~urroundlnp h--lthy t1~w. A~ u-~d bor~ln th~ to n ~und~
lneludo~ tut~l ~er~po~, ~brulon~ or t1~ d~ ~ e~u~ y
1n~ur~, tr~ urg~ry or d1~u~. Th~, thc p u~1c ~o~t~
~h1ch ~r~ kno~n to h offoct1vo ln th~ tr~t~nt o- ~04nd~ eu~,
~eeord1n~ to th1- 1nv~ntlon, b tollv r ~ ~pOcl~C~ to nund
~t~ ~1th n~ nonto~1e pho~phollp1t/ehol- t-rol t1puouo. tn
p~rtle~ler, th~ llpo~oo~ eont~ln~ng thcr p~tle ~nt~ ~r- ~ :
u~o-ul ~or tr ~tlq~ ~ound~ o~ tho on- p~r~1c~1~rl~ tho corn ~.
,
~ lpo~o~ - ~hlch c~n ~o u~ d ~ecord1n~ to th1- lnv~ntlon
1nclu~c ~ny 11po-o~ ~hlch ~lood~or~ to o ~o~n~ ~1te~
p~rt~cul-rl~ o corno-~ ~ound ~lto, ~nd ~ho~t no toxlc,
1nn ~ tor~ or ~t1h~ 9 ~ n~et~. Tho~ llpo-o~
co~pr1-- ~ 11pld nJ ~llt typ1e-11y eo~prl u 50~00 ~ol~ o~ on~ or
~or~ ~nthotle or n-tur~lly occurr1nB pho~phollp1d~ ~n~ 10 ~0 ; ~ :
~olor perc nt (~ol#) ehol u t~rol. ~ho~phol1p1d~ ~b~eh c~n b~
u-~d ln f~rrul~tl~ 11po~o~ or ~c cccor~tng to t~ ~r~nt
1nwnt10n lncludo~ pho~ph~t1dylchol1no, pho~ph~tldyl~lyc rol,
pho~ph~tldyloth nol~1no or pho~ph~tl ~l ur1no ~lth dl~c~t ch~lns
o~ typ~c~ 5~ to 1~ c~rbn~ ot ~lthor tho ~tu~t~d or ~onooM
v~r1~. Otiher llp1d~ cl~d1ng pho~phol1pl~ bl¢h c-n b~
u~d ln th~ ~or~ul~tlon o~ tho 11po~o~ elu~e, ht ~rc not
ii~
... .
'?
'i,, ,

Stl`~T ~1';L~WL PRl~E L~BLANC . . . i 4- 2-~D il~;4~AM i 7~30B41124~' 3~1 13~B;~ 7
~_ ~ %~13'7~0
11m1t~ to~~pho~ph-t1dy11no-1tol, ~ph1n~oly~ , pho~ph~t~tlc
~cld, cer~ro-1t--, c~rtlollpln ~nd ly~opha~phol1p1d~.
~ 11po~o~ c~n h prep-r d ~y ~ nu~b~r o~ ~ethod~,
1nclud1ng but ~ot llm1ted to, proeodur~ r pr~p~rlng
~ulS11~ r ~ un11~n~ r (SUY~ r~e un11u~ell-r
~L W J, plurll~m~ r ~5PLV) ~nd r v-r u ~ph U ~ ~v~poratl~n ~tV)
llpo~o~ o, ~. ~r~orl4dl~ a~ r~p~r~tlon
of 11po~o~o~, Vol.l Al~o ~o~ U S P~t~nt No. 4,a3~,~71, 1~-uo~
to P~p~h~d~opoulo~ ~t ~1., 1neorpor~t-d h~r~1n 4y r~rsnee to
th~ oxtont th~t lt t~4ch u th~ prop~r~tlon o~ 11POJO~H~ u~oful
~e~ordln~ to ~hc pr~n~ 1n~ntlon u d~-~r1 h d ~b w -
.
~ t hu ~l~o ~n ~ount. ccor~ to t~lo pruMtlnv~ntlon, th~ llpo~ hteh ~r~ r~l~ttv~ly ~ at 1~, iO
to ~0~ n-nom t~r~ 1n ~ t-r, pr~hr~bly 1--- th~n lO~ nm
~n dl~t~r ~hlblt m~x1~1 ~lount ~lt~ cwcr~je tn co~p~rl~on to
tho l~ger ~LV-type ll~ ot ~00 to ~0,000 n~ 1n d~t~r.
. .. ~ .
Th~ prof~rr~t llpo~o~ conpo~1t10n of tb~ pro~ont
l~ n ntlon co~prl u ~: pho~ph~tl~lcholl~o (lO colx)t eho
~ t1 nly ch~r~o~ pho~ph~tldyl~l~c-rol ~0 ~ol#), ~lth h th
pho~phollpld~ eont~ln1ng ~tyl eh~tn~ of p~l~ltle ~e1d ln tho
po~1tlo~, ~nd ol~1c ~C1t tn tho 2 po~ltlon~ ~d ehol~s~orol (20 -~
~ol~ For ~x1uu~ ~ound ew~rn~ tho pr~ h rr-t 11po~om~ ~r~
20 t~ ~00 n~ 1n dl~Jotor, pr~tcr~bly lc~ Sh~n ~00 nm. Th~
productto~ o~ l~poso~ o~ th~ 100 nu 1~ ~ceo~pl~lh~ by
p~lng ~LY llpo~o~s thro~h ~ Mlero~lul~t u rR ~lcrotluldl~,
Corp , N-w~o~, M~ nd gh~lr ~1 u ~llt typlo~ ry 1
th~n ~oYt ~0~
,
~h~n co~po~t of pbo~ph-t1ty1cholln~ ~th ~tur~t~d ~cyl
-~ th~1n~, th~ llp~o~u D~ th~ pr~-nt tnv~ntlon h-v- ~n qu~ou~ -
l~qu1d-cry~t~111no ph~ u tr~n~ltlon o~ h ~w~on about 3~ ~d ~2
, ~
.: .
~.:
,. ;, - -, . . ............ .
: . ............ - .
,. ~ . .. .
.... .. . . . ..
;. . . .
~,, .,; .. ~

S~NT ~;L~W~ ~RI~ OLA~ .,.i 4- 2-~ ;4~AM i 7~3~41124~ 3~1 13~8i3 8
; 3 ! ~ J 7
d~Qr~ eonttgr~do, pr~r~bly cl~o to th~ hum~n ph~lolo91c-1
t~p-r~tur~ of ~7 d~gr~- c~ntlgr~d~ ~h~ llpo~o~ - ot th~
pr~nt lnv-ntlon ~hl~h ~r~ eompo~d ot pho-ph~tltylcholtn- ~1th
~on~n~ cont~lnln~ ~cyl ch~n~, ~xhlb1t phn ~ tr~n~1t10n~
bolow ~ro tog h~ ccnetgr~d-, ~nd ~1JO ~ho~ oo~d blo~d~orp~
proportlo~ to ~ound ~lto~
nv-ntlon 1~ not 11~1tcd eo only pho~phollpld or
phosphol1pld/cholo~t~rol cont~1n1n~ llpo~, ht ~l~o compr1~s
pho~pholtp1t/cholo~torol 11~0~0~4~ cont~lnln~ polyr~r~ thU~
llpo~o~o-po1y~r co~bln~t10n- prov1d~ for for~ul~t1~n~ ~1th
~ner~od vl~eo~tt,Y ~n~ pol~ r ~hlch ~tll pro~ld~ for
lncruud V~C~S~ round tho l~po~o~ tl~l~ w1th
th~ tt~uos o~ tho ~y~ e~n h u~ pol~r(~ ~r~ ~dd~d to
for ~ co~po-ltlon ~tth ~ co~1ty o~ ~t~n ~out 5
cp~ lOOO cp~., prcf~r~bl~ bct~n ~hut ~S cp~. and 200 eP-.
of pol~r~ h1ch c~n ~ u~-d ~ccord1n~ to ~h~ m~thod~
of tht~ vont10n ~aelu~- n~tur~l pol~n wch u
:~ po~ cch~rld~ ,9. ~gln~t~, ~t~nh, odtf1cd C~llUlo~c~
u hy~roxyprop~l~thylc~llulou ~nd h~Ltro~w~thl~lc~llulo~
g~l~t1n~, ~l hmln, cu-tn. ch~to~n ~n~ eoll~n. In add1t1u~,
synthot1c pol~r~ ~hlch c~n ~ d lnclu~ polyl~ctld~glycol1d~
eopol~r, pol~l~ctlh, polyh~rox~ th~l~th~cryl~t-,
pol~torullltu, pot~orthc~t~r~, pol~th-cr~ t-,
pol~lnyl~lcol~ol, polyvln~lp~rrol1don-, poly~er~t 16 ac1t,
poly~tbyl-noglycol ~lt pol~rlc u~ C1d~. Tho 11po~ ln
tho~r vl~eou~ ~trlx prov1do tor lon~r ~ontlon of th~
for~ tlon ln th~ ~ ~nt th~ or~ ~10~d~0rpt10n ot th~
llpo w ~ ~ to th~ 1t~l oY~r 10np r t1~ p~r10d~
p~rccnt~g~ o~ po~yn~r 1n th~ 11po wn~ ~or~ul~t10n W111 ~p~nd on
thC poly~or 1t~olf, ~t 1n ~nrr~l th~ conc~ntr~tlon o~ polyn-r
r'.'l c~n r~ngc tro~ ~out o.a~ ~ t~o ~t.~. -
) ~ :
::

~NT Ol';L~W~ PR~ L~BLAI~ ... i 4- 2-Y~ AM i 7~841124-' 3~1 13~
20137't~
Thor~p~utlc ~en~ ~hlch c-n ~ ro~ ~o ~und ~1t~J
ln llpoJo~ or 11po-o~-~po1~-r ~or~Yl~t1on~ ~h1eh blo~d~orb to
uch ~1t-- co~prls~ ~11 thcr~p-ut1e ~nt~ uu r~ ~or th~
tr~tm~nt o~ ~ound~, eut~ ~nd ~r~lon~ c-u--~ br ln~ur~, tr~um~,
~ur~ry nt/or dl~ ueh thor-p~ut10 ~gcnt~ ~111 e
comprlu, ~ut ~ro not lt~1to~ to~ oro~th ~ctor~, ~torot~,
~ntlox1d~nt~, ~on-t~rold~l ~nt11n~1~r~tory ~g~t~, ~ntlblotle~,
l~no~ul~tor~, ~nt1~ rglc~ ~nd co~poun~ h IlIk~ uP
h~nt ~br~n~ uch ~ ~lbron~ct1n ~ . Furth~r -
: g~t~ lneludo ~lologle~l r~pon~ ~odl~l-n ~ gon~ ~h~-
ch~n1-~ o~ ~ct10n 1n wlv~ tho 1ndlv1du~ o~n ~to~o~le~l
r~po~3~ , Ol~hu~ L~ , Ch~pt~r ~,
- ~or~nc~ c~du~1e ~s-, l~5, ll~c4rpor~t~d h-r~1n ~r
,,,
k eord1n9 tO th~ pr~n~ lnv-ntlon, th~ 11PO~O~J
cont~lnln~ th~ th~r~pwt1e ~gcnt or ~rug tor th~ tn ~te~nt o~
wound~ ~r~ ~ppll~t top1c~ to tho ~po. As ~lll bo ~nt~r~too~
by tho~o ~klllo~ ln th~ ~t, th~ ~du1n~tr~t~on, ~qu~Rc~ o-
~d~tn1~tr~tlon ~hcn ~or~ th~n ono thor~p~ut1e ~nt 1~ u~-d, ~nd
th~ eo~eontr~t10n~ ot th~ th~r~pwt10 ~o-nt- 1n ~hc ltpo-om ~ o-
th pr~ont lnvont~on d~pon~ on nYo~roUt ~ctor~. ~h~ f~ctor~
c~n 1ncl~d ~ th ~poG~ thor p-utle ~I~ or ~o~t~ to h u U~
tho nIt~r~ 0~ th~ ~ound. ~nt v~rlou~ el1n1c~1 f~ctor~, 1noludtn~
'~ th~ ~xt~ nd qp~ of ~ound h1~g tr~N~-d, th~ ~H41e~1 hltt~ry
î~ of th~ p~t1~nt ~ ~pto~ oel~t~ ~lth tho ~ound, ~llch
1n~1~mn~tlon or ~d-o-, ~t~. t~l~ctlon of th~ ~p~lflc
th~r~poutle ~p nt ln th~ 11po~ . th~lr conc~ntr~tlon ~nd
-~ ~oqu~nc- o~ d~ll w ry to tho ~y~ ~111 h ~d~ ~y tho ~k~llod
G1~n ~11d~ th~ for~go1n~ d~Jer1et10n. Jn ~ddttlon,
b~ uu~ th- llp~-~s~-typ~ ~or~ul~tton ~1c~d~orb~ ~nq/or
b10~dh~r-- p~e~1c~ t~ th~ wound ~tt~, th~ ~ount ~nd
~- ~r~qu~ney o~ th~r~p wt1c ~g~nt nor~ tl~ ~dJlnl~ter~t u th~ tr~
~gent ~-n b~ r~due ~. Typ1e~11y, th~ ~ount o~ ~hor~p~utlc ~g~nt
,' ,:
. ,
,~; ,. , - . . .,. - . : .,
", ~ ~,
., .
, . "-

S~NT ~Y:L~\'It PRlC~ L~LANC .,. ; 4- 2~ :5~AII; ~030~41124' 3~1 13~8;J~10
~' ~J 2~1377~
-
~d~1n1~t~r;d ln 11PUO~ ec~rd1ng to ~ho pr~-nt lnvontlon c~
b~ r~ue~ by up ~o ~ut ~ th~ ~o~ ~ln1~t~ oth~r
~tho~ uch u 1n ~quoou~ drop~, o1nt~ntl Ot ou~pon~10~
~ h~ l'ollowlne ox~pl~ ~r ~ ct~d ~o th~ blnd1n~ of
11POJOII~ ~n~ llpo~ prl~ hor~p~utlc ~g~nt~ to corn~l
~oun~. r~ x~pl~ u-tr-t1n of th- pro~orontl~l
b~nd~ng o~ th~ llp~ to Itou~d olt~J~ ~ut ~hoy ~ro ln no ~y
1 1~1t1n~.
.
~ Phosph~tldyleholln~ ~ ~.U q/~l~
Pho~ph~t1~ ol
Cholut~rol 0.~
Dloet~d~t ~ ~t~tr ~ thyl.lndoc~rbocy~n~n~ ~ ~ o) 0.1~ ~ /~1 .-
:
t
' '
A11quot~ o~ pho-phol1pld- ~nd chol~torol 1~ chloro-or~
22.~ ~ pho~ t1d~cl~ol1n-, N.5 ~ pho-ph~t1~1glyc~rol, ~.
m~ chol~torol) ~ro ~ddd to ~ ~lu~ eont~1n~r. th~ ~luor~c~nt
. dy~ ~0.11~) ~ th~n ~d~ ~ ~n ~ uo~ ~n ~thonol. th~
:: ~o~-nt ~ th-n o~p~r~ct undcr rlltro~ h~ llp1
~uoruecnt dY- t`1h n~ th~n roh~r~t~ Y1th Dulb~eeo'~
pho~ph~to buff-r~ ~lln~ cont~lnln~ ~ e~ nd 0.4~ IIM
~gnulu~ ~lO ~ h~ p~ ~u ~wt~ to ?.~ ~1th d1~ut~
Xl~. ~h1~ r~tlon r~ul~d ln th- ~pont~n~ou~
for~tlon of ~ult~lu~ll~r llpo~
}'
~;~ Fro~hl~ tl~ t~ r~lt cornoi~ hc~ 1n ~SS
~lu~R ~leon L~hr~orl-J. Ine.). rh- corn~ ~ro pl~c~ ln
~''' .
~.,. ~.. ,. ~. - , . .. ..
~ ;. ~ . , ,., . ., , . . . . ~
~ . . .
r~ ~
,~ ',; ~.

StNT Br;~W~ ~RlC~ L~BI.AH~ . . . i 4- 2-~ ;51AM i 7~3~41124~ 3~1 1398;~11
~J rJ ~ 1 3 7 7 ~
pl~tlc cu n ur~ dl~ho~ ~nd o1thor cut or ~er~pcd ~odl~lly through
thc cplth~ ur~C~ wlth ~ ~c-1p~ do. 1~11t~
~ollow1n~ th~ cuttln~ or ~cr~Plng, l~ul o- ~h~ ~luorc~ccnt
l~ol~t llpo~ torlnul~t1~n w~ ~ppl~od to tbo eorn~l Jur~e-
Afhr ~ ln tho Corn-~- wcro wUh~d ~ tl~ ~1th ~ SS ~lwR
oC ln ~ C02 lncub~tor u~ln~ ~ rot~r~ ~h~r.
E~ch corno~ w~ ox~ln-d u~ln~ tluoro~c~nc~ mlcro~copy
by vl~wlng tho cornu- in ~ ch~r cr~to~ by two 91~
eovor-l1p~ tlttC~ ln ~ ~chln~d plUtlC f~ow ull. ~h~ flod c~ll
con~1-t~ of ~ pl~Stlc ~lock ~11 5 X ll.t e~ X l.t cm) ln whlch
tour 1 c~ hol-~ wor~ bor-d for vls~ln~ und~r ph~c. A r~c~ d
~rc~ -2.5 X 2,5 cm ~nd -a.5 mm doop ~ - u ch1nod ov~r ~nd ~roun~
o~ch hol- ~n~ X IS ~m cov~r~llp ~dh~r-t ~1th s111con
to th~ block wlthln th~ roc u s~d ~ro~. A th1n ~h611~w ln~-t
tg~ -0.~ p w~ chlno~ ~1thln th ~.5 X t.~ c~ r~c~J-d
~r~ for ~ceo~o~t1nS ~ top eo n r~l1p of 2~ X 25 ~ tdhot~d to -
~hc 1-~9- ~lng ~lllc~n gr~o. On t~o oppo~lto d~ u o~ thc
block, ~our ch-nn~ p~r ~ , n rc ~chln~d ~lowtn~ ~or
pl~c~ nt o~ ~yr~ng~ ~odl~ ch tlp ~u~t ~nt~rln~ onc o~ ~ch
o~ tho 2 ~ cr X ~.~ c~ X 2.~ ~ r~tol~-d eh~rb~r~ E~gh ~yrin~
n ndlo ~u h~ld ln pl~co ~lth ~ scr~ n -h-r t~x~d 1n th- N ock,
P~r~ t~ ~n~r~ thc ch~b~r~ th nu~h thc ~yr1n~ no~dl~ In
th~ cont~r of tho ~lock tnD lon~ ch~nnol~ c~ X I cr ~n~ o~-
cm d~p) 1~ n uld conn ctlon ~lth tho ch- b-r- ~nr~ ~chln~d
p~rpondlcul~r to thc ch~nnol- ho~1n~ th~ ~r~n~ noodl~ for
colloeS10n o~ por-u--t-. Durln~ cx uln~t10n tho nO~ c~
flxod to th~ ~t-g~ of th~ ~lcro~copc ~lth ~cr-w~ -
. ~
~ ch ~ount-d cornc~ ~u ln ~urn pl~c~d on ~n l~ X ~8 m~
cwcr~llp 1n on~ ch~bcr of th~ n~ 6011 ~n~ eo~orod wlth ~ 2~ X
25 mm top con ~11p Durlno oxu~ln~tlon thc corn~ u ~Hr~
con~t~nt1y por~uud ~1th ~S~ ~lu~ ~nd tho to~p~r~ur~
e~lnt~1n~d ~t ~C ~1d~o 1~o~ o~ tho ~luor~eont~ el~d
'..':
,,,
.
r 9
.
,., .
, . ~ . .

s~Nr ~:L~WE PRl~ Lt~LANC .,. . 4- 2-9~ ;lU:SlAM; '1~3~41124~ 3~1 139~;~12
~ V ~01~770
llpo~ pronn~ on thc corn~ ur~c~ ~ro r-~ort~t ~t -
~ynl~lc~tlon o~ 113~X. ~hc l~o~ ~ppo~ro~ bl-cl~ ~nd ~h1t- ~lth
th~ to r~lon~ r~prountln~ tho~o ~ro~ ln whl~h tho 1-~1cd
11po~o~ wer~ loc~tod. ~ho ~l~ck ~ro~ ~n tho 1~J
r~pr~cnto~ ~ru~ ~h~r~ no 1~hl~t llpo~ or pru-nt. On
Db~or~lng th~c 1~ o~, 1t ~ o~nd th~t th~ d llpo~
w~r- l~c~t~d w~tt~ntl~ll,v ln only th~ c4t er ~cr~p~ ~ltu.
Llttl~ to vlrtu~lly n~ l-hlcd lipoto~ ~h-Pod to th~ uneut or
un~cr~p~ ~r~ o~ ~ny o~ tl~- c~nn~. K~r w~ hl~
llposo~ ob~rv~d ~h~r1ng eO th~ corn~ n un~und~d or
"nor~-l" c~ w~ trc~e~ ~lth l-b-l~d ltpo~ ul~l wuh~
~co~dlng to tho ~bovo d~erlb~d ~roc~d~r~.
Tho l~p~ ~r~ th~n qua~t1t~t~ ~or t~ ar~ of ~hlt~
r~glon (1.~ hl1~ht~d ~tx~ hlch r~pr~Rt~d th~
blo~dsor~t llpo~omo~. ~h~s~ r~6ultJ ~r~l ~Xpl' J~d ~ corn~
sur~ rc~ (~a) t~ 3ho~n ln tho Fl~luro ~1th ~n ~nrag~
~t~nd~ rro~ ~ th~ ~n for ~lv~ dl-~sr flt 1~
3n tho ~1~ur~ 1t c~n b~ n ~hat ~u~ ntl~1tJ~ nD
l~b~l~d llpo~s ~h~r~d tO th~ UI~CUt or l~n~cr~p~ norul
oorn~ h~ l-b-l~ 11po~o~s lldh~ to about ~o ~ n
th~ ~ut eorn~ And ~ ~ ln tho Jer ~d corn~. Th~r~hr-.
llpo~ u-~ tcor~tn~ eo tb~ ~thod~ o~ th~ pr~nt lnv~ntlon
c~n bo u~ to dnt~v~r ~oun~ tr ~t1n~ ~pnt~ to ~ound~ b~us~
th~y prof~r~ntt~lly ~th~r~ to ~lound ~ltu ~nd not to unwound~
~tt~.
. .
'`
.
.
F
...
~"' ,
,^. ~D
, . .
` .
.
: . `
f ' '
,
~:' r

S~NT ~Y;L~JW~ PRIO~ Lt~LAN~ .. i 4- Z-~8 il~:S2AM i 7~388411~4-' 3~ 8;~13
V ~ 3 r~ l7 ~3
Th~ ~o~ no c~po~lt10~ c~n b~ ~ppl10d tOp1C~ to
tho y- to promot- r ~plth~ t10n o~ ~ ~ounet-d cor~lta.
Pho~ph~tl~ylchol ~n~
,~ Pho~ph~tldy~ol~ rol 1
- Cholo~t~rol 8 mg
Ep1t~ 1 6ro~h f~etor ~E~F) lo ~
... '
For th- pr-~r~t10n o~ 10 ~1 o1' co~ ltlon, th~
pho~photlpld~ and cholest~ r~ ~t~h~ a~ ~ry lybphlll~
po~d~r- 1n 1l 9l~ cont~ln~r ~a30 q pho~h~t1tylcho11 0 m~
pho~ph~ttdyl~ rol, 50 ~ chot~t-rol) ~ollo~ ~y th~ adt1tlon
o~ l ~1 t hlt~nol. ~h~ r- t~ th~n ~olubllt2~t by g!~tl~
.~ Inlxlnp ln ~ ~0C ~ ~r b~th, ~t-rll~ ~tlt~r~ n~ th-n ~r~u
- tr~t to r~nw~ ~ha t ~ut-nol. ~h~ oph111~ 1d po~d~r t~
-~ th~l~ r~hydrat~d ~t1th 1~0 ~ of ~or11- E~P ~ olv~ 1n
C~O~ pho~h~ u~ d J~lln- ~ont~lnlng 0.9 rM c~lc1~n
.n~ ~nd t.~ ~ n~n-~1u~ ~10 ~ h1~ r hYdr~t1on ~ lt ln
th~ spont~n~ou~ for~tl~n of ~ultll~tl~r 11po~ co~t-1n1n~
. E~F. ~o ~x~ z~ ~n~r~ Hnt o~ EQF 11~ tho ltpo~ h6
~ormul~tl~n 1s ~rn ~- dr1~ c~n~ tl~o th~n ~h~dr~t~ wlth
. ~lbl ~t~rll~ do10n1~ t~r ~or~ UJC.
: ', .
, .
,: -
:~
i:
11
, ~ . - .~ .
. ... . ~ . - . -.
. .
,-:. ~. . . .

:i~N~ ~r.~we I'R~e Le~LA~ .. i 4- 2~ ZAI~ i 7~3~0~ 4' 3~1 13~ 14
(--' U 2013770
-
f~tlo~lng t~ ~n ~xullpl~ o~ ~ llpo~o~/pol~r
~nul~t10n to llhl~h th~r~p~ut1c g-nt~ c~n b~ ~dd~ tor ~h~
tr~t~nnt o~ corn~ ount-
In~
~p~1~1toyl~2 ol~o,Yl~
phsJph~t1~1chol1n~ onnul~tlon
," ~.P~l~ton-t-ol~y~ .
pho~ph~t1dyl61yc~ t .~ or~ t10n
ch~ torol 0.~8 ~l ~or~ul~tlon
g~l~tll~ t~ o~ul~t10n
: .
e~
Th~ ~ho~hollp1~- ~ cholo~t~ h~ ~ t~y
lyophlll~ dors 1n ~ eontnln~r fol~ h~ ~tld1tlon
~f ~ ry~anol l~out ~ ml/J ~ o~ to~l llp1~. Ltp~phll~c
tru~ ~nt th~r~p-ut1e ~nt~ ~hleh ~r~ ~olllbl~ 1n t~r~1~ry
but~nol e-n bo ~ t th1~ po1nt ~t eollc-ntr~10n- ~ct1n
~r th~ tn~t~nt o~ ~un~. T~ ~1xtur~ h~n co~plat~ly
Itolub111~ golltl~ ~lxlng ln ~ ~0C nt~r l~ath and th~n fr~uo
drlod to r~ovo th~ t~r~ but~nal . ~h~ po~d~r 1
r~hydr~t~d ~1th Dulbocco'~ pho~ph-t~ ~u~ d ~lln~ eont~lnln~
L ~ o.~ ~ o~ n~ 0.4~ gn~ . Tht pH 1~ ~J~u~t~d to ~
~- wlth d11ut~ ~odtu~ hYdnx1t~ t~r tol4bl~ drug~ ant
~-` th~rapwt~t ~nt~ ueh u gro~h ~etort. c~n ~ ~W~d ~e thls
~; po1nt Jlt eoncentr~tlon~ nft~etl~ r ~h~ tr~nt of ~ound~.
~ult~l~llu 11po~ cont~lntn~ ~ru~ or th~r~p~utle ~nt~
. ~r~ for~d by lncub~lt1O~ ~nd ~1~tlng ln ~ roe~ry nt~ b~th ~t
0C~ For ~ ntr~ t ~ tcr ~olubl~ d~gJ ~n~
h~r~pcut1e ~ tt, th~ ~olYt1on c~n b tn~ rl~ ~ln ~nd
~,,
~,",
,.............. ..
"
, - - , ., , ...
., - . . .
,. - '~ ,
~ . .
.,, ~ ,
, ,

5~NT Ol;L~We F'R~ L~ISLAI~; .. i 4- Z-~ 3AM i 7~3t841124~ 301 13~8i~15
3 7 7 ~
--
o~1n n~ r~h~dr~t~d w1th ~t~r to~lo~d by ~urth-r
1ncub~tlon ~n~ ~lx1n~ ln ~ rot~ t~r b~th ~t ~0C. . I~ ~m~ r
unll~ r llpo~o~s ~ro ~lr~d tho oultll~soll~r 11po~o~ c~n
b~ P~Ud tllrouo~ ~ MlcrofluldlurR (~lcronuldlc~. Corp.
rop~t~ly unt11 tho d~lr~d pr~por~lon of
obt~1n~. ~ ppr~ tod by tho-~ klll~ th~
Jom~ ltpo~ol- for~ul~tlon~, for ox~mple, ~ouo of tho~ cont~lnln6
prot~ln~, ~houl~ not b~ p u ~d throug~ th~ ~lcro n u1~1 u r b~c!u--
of d~n~tur-tlon of tho prot~n. ~ t stop, po~d~ro~ g~l~tln
(S~n~ ln typ~ I, Slg~- Ch~41c~1 Co., St. Loul~, ~0.) 1~ t
~t ~ eoncentr~t10n o~ ~5 n9/~l formul~tlon. 'rho ~1x~ur- 1~ th-n
;~ntly ho~too ~n~ ~lx~d ~t ~Dt u~t11 tr~ pl~t1n 1~ ~olub1111~d.
~ . ; .
.
.
. . .
.
,,., :
:.,
., :
,",~ '
.~
'~"
... .

i-'
~ '
. . '
i" . ' ' . ~ . ` .
i' :, ' :. ,
~''-"' ~ ' ' ' ',
7 ' ' ~ ' ' .

Representative Drawing

Sorry, the representative drawing for patent document number 2013770 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 1993-10-04
Application Not Reinstated by Deadline 1993-10-04
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1993-04-05
Inactive: Adhoc Request Documented 1993-04-05
Application Published (Open to Public Inspection) 1990-10-04

Abandonment History

Abandonment Date Reason Reinstatement Date
1993-04-05
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ALCON LABORATORIES, INC.
Past Owners on Record
DIANA M. CORDOVA
JACK M. SHAW
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1990-10-03 1 22
Claims 1990-10-03 4 131
Drawings 1990-10-03 1 16
Descriptions 1990-10-03 13 497
Fees 1993-01-13 1 43
Fees 1992-03-23 1 41
Fees 1992-01-14 1 37